mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.04 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.05 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |